Search results for "Statins"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
Studies highlight limitations, potential alternatives to common risk equations for CVD
Removing race from the pooled cohort risk equations for cardiovascular disease (CVD) did not affect accuracy, according to results of a recent study, while another tested a prediction model based only on sex, age, and routine lab tests.
https://immattersacp.org/weekly/archives/2023/12/12/1.htm
12 Dec 2023
U.S. statin use plateaued in 2013 to 2018
Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
https://immattersacp.org/weekly/archives/2023/12/05/1.htm
5 Dec 2023
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Studies, CMS look at lowering prescription prices
Even as Medicare seeks to negotiate down the costs of 10 prescription drugs, researchers are examining the effectiveness of existing private programs to provide lower drug costs and copays.
https://immattersacp.org/weekly/archives/2023/09/05/1.htm
5 Sep 2023
Use caution with colchicine's many drug interactions
A coauthor of “The Top 100 Drug Interactions” offers advice for improved management of colchicine.
https://immattersacp.org/archives/2023/09/use-caution-with-colchicines-many-drug-interactions.htm
1 Sep 2023
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023